Accent Therapeutics Funding: $178M Raised, Series C (2024)

Accent Therapeutics funding overview

Accent Therapeutics is based in Lexington, Massachusetts. Accent Therapeutics has raised $178M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in January 2024. The round record for Accent Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Mirae Asset Capital Life Science, Bristol Myers Squibb, Johnson & Johnson Innovation – JJDC, The Column Group, Atlas Venture, Droia Ventures and 5 others. 11 distinct backers are named across the disclosed rounds.

Accent Therapeutics at a glance

Total raised: $178M
Latest round: Series C
Latest round date: January 2024
Headquarters: Lexington, Massachusetts
Notable investors: Mirae Asset Capital Life Science, Bristol Myers Squibb, Johnson & Johnson Innovation – JJDC, The Column Group, Atlas Venture, Droia Ventures, GV, EcoR1 Capital

Frequently asked about Accent Therapeutics funding

How much has Accent Therapeutics raised?: Accent Therapeutics has raised $178M in total disclosed funding across the rounds on record.
Who has invested in Accent Therapeutics?: Mirae Asset Capital Life Science, Bristol Myers Squibb, Johnson & Johnson Innovation – JJDC, The Column Group, Atlas Venture, Droia Ventures are named among the investors backing Accent Therapeutics.
What was the latest Accent Therapeutics funding round?: The most recent disclosed round is a Series C, announced in January 2024.
Where is Accent Therapeutics based?: Accent Therapeutics is based in Lexington, Massachusetts.
When did Accent Therapeutics last raise?: The last disclosed Accent Therapeutics round closed in January 2024 at Series C.

Round data for Accent Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Lexington and backer lists below.

Accent Therapeutics Funding: $178M Raised, Series C (2024)

Accent Therapeutics funding overview

Accent Therapeutics at a glance

Frequently asked about Accent Therapeutics funding

Companies related to Accent Therapeutics (13)

Browse related funding lists (7)